0000899243-19-016441.txt : 20190611
0000899243-19-016441.hdr.sgml : 20190611
20190611181009
ACCESSION NUMBER: 0000899243-19-016441
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190607
FILED AS OF DATE: 20190611
DATE AS OF CHANGE: 20190611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cima Michael J.
CENTRAL INDEX KEY: 0001615992
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 19892010
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-07
0
0001492674
T2 Biosystems, Inc.
TTOO
0001615992
Cima Michael J.
101 HARTWELL AVE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2019-06-08
4
M
0
9000
A
216418
D
Restricted Stock Units
2019-06-08
4
M
0
9000
0.00
A
Common Stock
9000
9000
D
Stock Option (Right to Buy)
1.54
2019-06-07
4
A
0
22000
0.00
A
2029-06-07
Common Stock
22000
22000
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On June 8, 2018 the reporting person was granted 9,000 restricted stock units that vested on June 8, 2019.
The stock option vests and becomes exercisable in 12 substantially equal monthly installments commencing June 7, 2019.
/s/ John Sprague, Attorney-in-fact
2019-06-11